SOLIGENIX, INC. Notes Payable, Noncurrent
SOLIGENIX, INC. (SNGX) had Notes Payable, Noncurrent of $162.49 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities › Notes Payable, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2020-11-12
- 2020-09-30: Notes Payable, Noncurrent $162.49K.
- 2020-06-30: Notes Payable, Noncurrent $232.13K.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2020-09-30 | $162.49K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $232.13K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |